The value of interferon combined with hepatic artery chemoembolization and portal vein chemotherapy in preventing a recurrence after radical resection for hepatocellular carcinoma

2005 ◽  
Vol 2 (2) ◽  
pp. 558-562
Author(s):  
Honghao Li ◽  
Hongwei Zhang ◽  
Jie Wang ◽  
Erwei Song ◽  
Jisheng Chen
2004 ◽  
Vol 4 (5) ◽  
pp. 782-787 ◽  
Author(s):  
Paul H. Hayashi ◽  
Michael Ludkowski ◽  
Lisa M. Forman ◽  
Michael Osgood ◽  
Stephen Johnson ◽  
...  

Author(s):  
M Juraev ◽  
O Nematov ◽  
A Yusupbekov

Importance: Treatment of hepatocellular carcinoma remains a topical issue of Clinical Oncology. More than 80% of cases hepatocellular carcinoma develops in the presence of liver cirrhosis. These patients are doomed, many clinics they held only symptomatic treatment and life expectancy of patients is not more than 6 months. The main reason for the refusal of surgeons and Chemotherapeutists of treatment is associated cirrhosis.Purpose: To improve results of surgical treatment of liver cancer developed on cirrhosisMaterials and methods: We analyzed the immediate results of treatment of 12 patients with hepatocellular carcinoma developed on a background of liver cirrhosis. From - the large size of the tumor and associated liver cirrhosis, these patients the first stage of oil produced by hepatic artery chemoembolization of the affected lobe of the liver tumor. After 2 - 3 weeks performed liver resection.Results: After analyzing the results, we concluded: chemoembolization reduces tumor volume and weight, increases the physiological regeneration of hepatocytes unaffected tumor fraction, improves functional performance of the liver and does not affect the frequency and severity of postoperative complications.


Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 766-767
Author(s):  
M OSGOOD ◽  
P HAYASHI ◽  
M LUDKOWSKI ◽  
S JOHNSON ◽  
D JANET ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document